Zevenbergen Capital Investments LLC Castle Biosciences Inc Transaction History

Zevenbergen Capital Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$16.0 - $45.99 $5.38 Million - $15.5 Million	-336,055 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$33.17 - $46.98 $1.09 Million - $1.55 Million	-32,976 Reduced 8.94%	336,055 $15.1 Million
Q4 2021 Feb 11, 2022	SELL	$39.06 - $67.58 $6.09 Million - $10.5 Million	-155,842 Reduced 29.69%	369,031 $15.8 Million
Q3 2021 Nov 12, 2021	SELL	$60.13 - $77.6 $1.09 Million - $1.4 Million	-18,053 Reduced 3.33%	524,873 $34.9 Million
Q2 2021 Aug 11, 2021	BUY	$50.07 - $76.78 $13.3 Million - $20.4 Million	265,126 Added 95.44%	542,926 $39.8 Million
Q1 2021 May 12, 2021	BUY	$58.92 - $97.33 $16.4 Million - $27 Million	277,800 New	277,800 $19 Million

202

26M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $804M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Zevenbergen Capital Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Zevenbergen Capital Investments LLC with notifications on news.